Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
If the answer is yes, schedule an evaluation
Nagashima, M
What recent regulatory changes have impacted diabetes medication accessibility in South Korea?
Indications: FDA approved: Type II diabetes - monotherapy or combination therapy Can be combined as adjunct therapy with other hypoglycemics including metformin, thiazolidinediones, or insulin regimens (Dungan & DeSantis 2015) Because it does not work when your blood sugar is low, it is unlikely to produce dangerous levels of hypoglycemia has been observed in clinical trials (in contrast to GLP-1 incretin mimetics, such as exenatide, which produce moderate weight loss)
US$ 23.02
US$ 23.26
US$ 29.86
US$ 25.96
US$ 20.44
